Figure 2. Cumulative event curves for clinical outcomes stratified by the method for definition of PPM in a competing analysis.

A, B & C) Clinical outcomes according to measured PPM. D, E & F) Clinical outcomes according to predicted PPM_THV. For competing risks of death, or in case of cardiovascular death, of non-cardiovascular death, subdistributions of the hazard ratio (sHR) with 95% confidence intervals (95% CI) are reported. HR_adjusted: adjusted hazard ratio; PPM: prosthesis-patient mistmatch; PPM_THV: PPM defined by the normal reference values of EOA for each size and model of implanted transcatheter heart valve; TAVR: transcatheter aortic valve replacement